Markets were mostly high on COVID-19 vaccine approval
The US
The prospects of new restrictions to curb the spread of COVID-19 infections caused most of the benchmarks to close in the red. USA30 fell 0.62%, while USA500 dropped 0.49%. TECH100 jumped 0.50%.
Crude oil closed the session at $47.15 a barrel after it gained 1.3%.
Gold fell 0.7% to $1,830.25 per ounce.
Asia and Australia
In part, investors were cheered by Pfizer's COVID-19 vaccine's latest approval by the US Food and Drug Administration.
Japan225 rose 0.59%.
HongKong45 lost 0.04% after some major companies like Alibaba, Tencent-backed China Literature, and Hive Box Technology got fines from its market regulator.
Down under, Australia200 gained 0.51% as the market expects the minutes from the Reserve Bank of Australia's latest policy meeting.
Europe
The Brexit negotiations were extended past the Sunday deadline, which led the markets to trade higher. The UK's Prime Minister Boris Johnson and EC President Ursula von der Leyen continue to negotiate a trade deal.
Germany30 and France40 each closed 0.8% higher. UK100 added 0.1%.
Brent oil closed 1.2% higher at $50.55 per barrel.
EUR/USD traded at 1.2144 after it went up 0.3%.
Sources: investing.com, reuters.com
Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation.
Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance is not a reliable indicator of future results.
